Literature DB >> 4135844

Comparison of spectrophotometric and gas-liquid chromatographic measurements of serum diphenylhydantoin concentrations in epileptic out-patients.

D Janz, D Schmidt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4135844     DOI： 10.1007/bf00594088

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  15 in total

1.  SERUM PHENYTOIN DETERMINATIONS IN EPILEPTICS.

Authors:  P A STENSRUD; H PALMER
Journal:  Epilepsia       Date:  1964-12       Impact factor: 5.864

2.  Micromethod for the determination of diphenylhydantoin in plasma and cerebrospinal fluid--a comparison between a gas chromatographic and a spectrophotometric method.

Authors:  A Berlin; S Agurell; O Borgå; L Lund; F Sjöqvist
Journal:  Scand J Clin Lab Invest       Date:  1972-05       Impact factor: 1.713

3.  An isothermal GLC determination of the plasma levels of carbamazepine, diphenylhydantoin, phenobarbitone and primidone.

Authors:  P A Toseland; J Grove; D J Berry
Journal:  Clin Chim Acta       Date:  1972-05       Impact factor: 3.786

4.  Studies of anticonvulsant levels in epileptics. I. Serum diphenylhydantoin concentrations in a group of medically indigent outpatients.

Authors:  A F Haerer; J B Grace
Journal:  Acta Neurol Scand       Date:  1969       Impact factor: 3.209

5.  Variations of serum diphenylhydantoin concentrations in epileptic out-patients.

Authors:  H Vapaatalo; L Lehtinen
Journal:  Eur Neurol       Date:  1971       Impact factor: 1.710

6.  Quantitative estimation of diphenylhydantoin, primidone and phenobarbital in plasma by gas-liquid chromatography.

Authors:  H J Kupferberg
Journal:  Clin Chim Acta       Date:  1970-08       Impact factor: 3.786

7.  Sources of error in the determination of phenytoin (Dilantin) by Svensmark & Kristensen's method.

Authors:  M Kristensen; J M Hansen; O E Hansen; V Lund
Journal:  Acta Neurol Scand       Date:  1967       Impact factor: 3.209

8.  Aspects of the pharmacology of phenytoin (dilantin) and phenobarbital relevant to their dosage in the treatment of epilepsy.

Authors:  F BUCHTHAL; O SVENSMARK
Journal:  Epilepsia       Date:  1960-06       Impact factor: 5.864

9.  Quantitative assay of 5,5-diphenylhydantoin (Dilantin) and 5-(p-hydroxyphenyl)-5-phenylhydantoin by gas-liquid chromatography.

Authors:  T Chang; A J Glazko
Journal:  J Lab Clin Med       Date:  1970-01

10.  The rate of decline of diphenylhydantoin in human plasma.

Authors:  K Arnold; N Gerber
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.903
View more
  2 in total

1.  [Plasma concentrations after injection or infusion of phenytoin (author's transl)].

Authors:  D Schmidt; A Vogel
Journal:  Klin Wochenschr       Date:  1977-03-01

2.  Factors influencing blood concentrations of chlordiazepoxide: a use of multiple regression analysis.

Authors:  D J Greenblatt; J S Harmatz; D R Stanski; R I Shader; K Franke; J Koch-Weser
Journal:  Psychopharmacology (Berl)       Date:  1977-11-15       Impact factor: 4.530
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.